Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Ligand Binding Sites02:40

Ligand Binding Sites

Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Ligand Binding Sites02:40

Ligand Binding Sites

Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Conserved Binding Sites01:49

Conserved Binding Sites

Many proteins’ biological role depends on their interactions with their ligands, small molecules that bind to specific locations on the protein known as ligand-binding sites. Ligand-binding sites are often conserved among homologous proteins as these sites are critical for protein function.
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally analyses the...
Cooperative Allosteric Transitions01:58

Cooperative Allosteric Transitions

Cooperative allosteric transitions can occur in multimeric proteins, where each subunit of the protein has its own ligand-binding site. When a ligand binds to any of these subunits, it triggers a conformational change that affects the binding sites in the other subunits; this can change the affinity of the other sites for their respective ligands. The ability of the protein to change the shape of its binding site is attributed to the presence of a mix of flexible and stable segments in the...
The Equilibrium Binding Constant and Binding Strength02:18

The Equilibrium Binding Constant and Binding Strength

The equilibrium binding constant (Kb) quantifies the strength of a protein-ligand interaction. Kb can be calculated as follows when the reaction is at equilibrium:
Ligand Binding and Linkage00:49

Ligand Binding and Linkage

Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked.  In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Novel Small-Molecule Analogues of IU1 Ameliorate Amyloid-β Mediated Toxicity in Alzheimer's Disease Cell and Worm Models.

International journal of molecular sciences·2026
Same author

Commentary on: Gutierrez RE, Prokesch EJ. The false promise of firearms examination validation studies: Lay controls, simplistic comparisons, and the failure to soundly measure misidentification rates. J Forensic Sci. 2024;69(4):1334-9. https://doi.org/10.1111/1556-4029.15531.

Journal of forensic sciences·2024
Same author

Small-molecule targeting AMPA-mediated excitotoxicity has therapeutic effects in mouse models for multiple sclerosis.

Science advances·2023
Same author

Results of the 3D Virtual Comparison Microscopy Error Rate (VCMER) Study for firearm forensics.

Journal of forensic sciences·2020
Same author

Quetiapine Excretion Into Human Breast Milk.

Journal of clinical psychopharmacology·2018
Same author

Most Ligand-Based Classification Benchmarks Reward Memorization Rather than Generalization.

Journal of chemical information and modeling·2018
Same journal

PFASGroups: An Open-Source Framework for Automated Identification, Structural Classification, and Prioritization of Per- and Polyfluoroalkyl Substances.

Journal of chemical information and modeling·2026
Same journal

DeepKbhb: Context-Aware Prediction of Human Lysine β-Hydroxybutyrylation Sites.

Journal of chemical information and modeling·2026
Same journal

HyperDC: A Non-Uniform Hypergraph Framework for Dual- and Higher-Order Drug Combination Recommendation Across Diverse Complex Diseases.

Journal of chemical information and modeling·2026
Same journal

Correction to "AstraMEV (AI-Guided Structural Assembly of Multi-Epitope Vaccines) Against Infectious Bronchitis Virus".

Journal of chemical information and modeling·2026
Same journal

MolPy: A Large Language Model-Friendly Toolkit for Reactive Topology Editing in Polymer Simulations.

Journal of chemical information and modeling·2026
Same journal

Molecular Mechanisms of KIT Receptor Dimerization and Oncogenic Activation Revealed by Multiscale Simulations.

Journal of chemical information and modeling·2026
See all related articles

Related Experiment Video

Updated: Jun 20, 2026

Pharmacophore Modeling for Targets with Extensive Ligand Libraries: A Case Study on SARS-CoV-2 Mpro
05:50

Pharmacophore Modeling for Targets with Extensive Ligand Libraries: A Case Study on SARS-CoV-2 Mpro

Published on: September 26, 2025

Predicting multiple ligand binding modes using self-consistent pharmacophore hypotheses.

Izhar Wallach1, Ryan Lilien

  • 1Department of Computer Science, Donnelly Centre for Cellular and Biomolecular Research, University of Toronto, Toronto, Ontario, Canada. izharw@cs.toronto.edu

Journal of Chemical Information and Modeling
|August 29, 2009
PubMed
Summary
This summary is machine-generated.

This study improves protein-ligand binding mode prediction by evaluating docking poses against a pharmacophoric map. This method enhances accuracy for known binders, aiding drug discovery.

More Related Videos

Elucidation of the Material Basis of Yiqi Qingjie Formula Against IgA Nephropathy Using UHPLC-Q-Orbitrap HRMS Integrated with Network Pharmacology
08:44

Elucidation of the Material Basis of Yiqi Qingjie Formula Against IgA Nephropathy Using UHPLC-Q-Orbitrap HRMS Integrated with Network Pharmacology

Published on: May 19, 2026

Related Experiment Videos

Last Updated: Jun 20, 2026

Pharmacophore Modeling for Targets with Extensive Ligand Libraries: A Case Study on SARS-CoV-2 Mpro
05:50

Pharmacophore Modeling for Targets with Extensive Ligand Libraries: A Case Study on SARS-CoV-2 Mpro

Published on: September 26, 2025

Elucidation of the Material Basis of Yiqi Qingjie Formula Against IgA Nephropathy Using UHPLC-Q-Orbitrap HRMS Integrated with Network Pharmacology
08:44

Elucidation of the Material Basis of Yiqi Qingjie Formula Against IgA Nephropathy Using UHPLC-Q-Orbitrap HRMS Integrated with Network Pharmacology

Published on: May 19, 2026

Area of Science:

  • Computational chemistry
  • Structural biology
  • Drug discovery

Background:

  • Accurate prediction of ligand binding modes is crucial for accelerating drug discovery.
  • Current virtual screening methods still require experimental validation for precise binding modes.
  • Experimental structural biology is often used to guide lead optimization after initial compound identification.

Purpose of the Study:

  • To develop an improved method for predicting protein-ligand binding modes for known binders.
  • To enhance the accuracy of virtual docking predictions by focusing on known interacting ligands.
  • To reduce the reliance on wet-lab experiments in the early stages of drug discovery.

Main Methods:

  • The algorithm performs traditional protein-ligand docking for known binders.
  • Candidate binding modes are evaluated for self-consistency with a generated pharmacophoric map.
  • The approach identifies a set of poses that maximally exploit key interaction points within the active site.

Main Results:

  • The algorithm achieved predictions with an average RMSD < 2.5 Å across four tested protein systems.
  • This represents a significant improvement of 0.5-1.0 Å (up to 25%) over naive docking predictions.
  • The method demonstrated effectiveness for thrombin, CDK2, DHFR, and HIV-1 protease.

Conclusions:

  • The developed algorithm offers a substantial improvement in protein-ligand binding mode prediction accuracy.
  • This method is independent of the specific docking technique used.
  • It has the potential to significantly enhance the reliability of virtual docking in drug discovery research.